Location: Menlo Park, CA
CIK: 0001631134 · Show all filings
Period: Q3 2019 (← Previous) (Next →)
Filing Date: Nov 14, 2019
Total Value: $1.106B (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| ASND | Ascendis Pharma A/S | 1,109,874 | $107M | 9.7% | $69.98 | — | ADR | 04351P101 |
| NTRA | Natera | 3,100,560 | $102M | 9.2% | $9.81 | +201.4% | COMM | 632307104 |
| — | Amarin | 5,208,305 | $78.96M | 7.1% | $7.81 | — | ADR | 023111206 |
| — | Nextcure, Inc | 2,521,856 | $77.8M | 7.0% | $14.98 | — | COMM | 65343E108 |
| — | Y-mAbs Therapeutics, Inc | 2,104,278 | $54.84M | 5.0% | $26.56 | — | COMM | 984241109 |
| — | Spark Therapeutics | 481,270 | $46.67M | 4.2% | $66.59 | — | COMM | 84652J103 |
| — | Principia Biopharma | 1,417,258 | $40.02M | 3.6% | $28.92 | — | COMM | 74257L108 |
| — | ObsEva SA | 4,749,623 | $39.56M | 3.6% | $13.49 | — | COMM | H5861P103 |
| CHRS | Coherus BioSciences | 1,933,221 | $39.17M | 3.5% | $10.94 | +82.6% | COMM | 19249H103 |
| — | Merus N.V. | 1,961,039 | $34.95M | 3.2% | $18.53 | — | COMM | N5749R100 |
| — | Karuna Therapeutics, Inc. | 1,729,352 | $28.22M | 2.6% | $20.02 | — | COMM | 48576A100 |
| — | Health Care Select Sector SPDR | 300,000 | $27.04M | 2.4% | — | — | Put | 81369Y950 |
| — | Audentes Therapeutics | 933,640 | $26.23M | 2.4% | $30.05 | — | COMM | 05070R104 |
| BMY | Bristol-Myers Squibb Co | 478,349 | $24.26M | 2.2% | $36.53 | +0.6% | COMM | 110122108 |
| — | Allergan plc | 134,433 | $22.62M | 2.0% | $154.55 | — | COMM | G0177J108 |
| VRTX | Vertex Pharmaceuticals Inc | 121,690 | $20.62M | 1.9% | $176.04 | +0.5% | COMM | 92532F100 |
| AMGN | Amgen Inc | 92,300 | $17.86M | 1.6% | $158.01 | 0.0% | COMM | 031162100 |
| — | Nucana Biomed Ltd | 2,400,000 | $17.38M | 1.6% | $19.00 | — | Ordinary Shares | GB00BYWYV |
| NBIX | Neurocrine Biosciences Inc | 191,679 | $17.27M | 1.6% | $89.01 | +5.0% | COMM | 64125C109 |
| — | Nucana Biomed Ltd | 2,266,666 | $16.41M | 1.5% | $15.80 | — | ADR | 67022C106 |
| — | Acceleron Pharma Inc | 408,262 | $16.13M | 1.5% | $40.44 | — | COMM | 00434H108 |
| UTHR | United Therapeutics Corp | 194,014 | $15.47M | 1.4% | $80.53 | 0.0% | COMM | 91307C102 |
| PFE | Pfizer Inc | 410,607 | $14.75M | 1.3% | $27.02 | 0.0% | COMM | 717081103 |
| — | Reata Pharmaceuticals Inc | 148,669 | $11.94M | 1.1% | $74.49 | — | COMM | 75615P103 |
| — | Reata Pharmaceuticals Inc | 148,600 | $11.93M | 1.1% | — | — | Put | 75615P953 |
| — | Iterum Therapeutics | 1,726,514 | $9.962M | 0.9% | $10.89 | — | COMM | G6333L101 |
| HALO | Halozyme Therapeutics Inc | 636,167 | $9.867M | 0.9% | $16.18 | +1.8% | COMM | 40637H109 |
| TGTX | TG Therapeutics Inc | 1,733,628 | $9.734M | 0.9% | $6.96 | +0.1% | COMM | 88322Q108 |
| PTCT | PTC Therapeutics Inc | 287,245 | $9.715M | 0.9% | $39.49 | +10.2% | COMM | 69366J200 |
| — | Chiasma | 1,630,221 | $8.07M | 0.7% | $1.49 | — | COMM | 16706W102 |
| SRPT | Sarepta Therapeutics Inc | 106,414 | $8.016M | 0.7% | $118.10 | 0.0% | COMM | 803607100 |
| — | Kiniksa Pharmaceuticals, Ltd | 922,700 | $7.852M | 0.7% | $17.35 | — | COMM CL A | G5269C101 |
| MGNX | MacroGenics Inc | 581,554 | $7.421M | 0.7% | $16.83 | -14.4% | COMM | 556099109 |
| — | Aimmune Therapeutics Inc | 346,770 | $7.261M | 0.7% | $20.94 | — | COMM | 00900T107 |
| — | Entasis Therapeutics Holdings Inc. | 1,180,178 | $7.034M | 0.6% | $10.88 | — | COMM | 293614103 |
| — | Kadmon Holdings Inc | 2,609,758 | $6.577M | 0.6% | $2.74 | — | COMM | 48283N106 |
| — | Dermira Inc | 990,168 | $6.327M | 0.6% | $8.90 | — | COMM | 24983L104 |
| — | Beigene Ltd | 50,000 | $6.123M | 0.6% | — | — | Call | 07725L902 |
| — | MyoKardia Inc | 113,926 | $5.942M | 0.5% | $52.16 | — | COMM | 62857M105 |
| FATE | Fate Therapeutics Inc | 381,600 | $5.926M | 0.5% | $19.17 | 0.0% | COMM | 31189P102 |
| FOLD | Amicus Therapeutics Inc | 722,974 | $5.798M | 0.5% | $12.56 | -13.6% | COMM | 03152W109 |
| BMRN | Biomarin Pharmaceutical Inc | 84,896 | $5.722M | 0.5% | $87.63 | -12.1% | COMM | 09061G101 |
| — | Dicerna Pharmaceuticals Inc | 342,755 | $4.923M | 0.4% | $14.36 | — | COMM | 253031108 |
| AKBA | Akebia Therapeutics Inc | 1,227,191 | $4.811M | 0.4% | $5.75 | -25.5% | COMM | 00972D105 |
| — | Zymeworks Inc | 188,438 | $4.672M | 0.4% | $22.00 | — | COMM | 98985W102 |
| XBIT | XBiotech Inc | 358,663 | $3.751M | 0.3% | $7.09 | -1.0% | COMM | 98400H102 |
| — | Foamix Pharmaceuticals Ltd | 1,199,254 | $3.645M | 0.3% | $4.42 | — | COMM | M46135105 |
| — | Otonomy Inc | 1,437,965 | $3.436M | 0.3% | $2.80 | — | COMM | 68906L105 |
| — | Orchard Therapeutics PLC | 283,406 | $3.367M | 0.3% | $15.62 | — | ADR | 68570P101 |
| — | Forty Seven Inc | 519,298 | $3.335M | 0.3% | $7.38 | — | COMM | 34983P104 |
| — | Calithera Biosciences Inc | 964,852 | $2.982M | 0.3% | $3.53 | — | COMM | 13089P101 |
| — | ArQule Inc | 393,387 | $2.82M | 0.3% | $5.46 | — | COMM | 04269E107 |
| — | Homology Medicines Inc | 146,297 | $2.647M | 0.2% | $18.09 | — | COMM | 438083107 |
| CYTK | Cytokinetics Inc | 210,992 | $2.401M | 0.2% | $12.55 | 0.0% | COMM | 23282W605 |
| — | Mirati Therapeutics Inc | 30,800 | $2.399M | 0.2% | $77.89 | — | COMM | 60468T105 |
| HRTX | Heron Therapeutics Inc | 123,400 | $2.283M | 0.2% | $25.45 | -27.7% | Call | 427746102 |
| ACRS | Aclaris Therapeutics | 1,911,573 | $2.064M | 0.2% | $19.07 | -92.6% | COMM | 00461U105 |
| HRTX | Heron Therapeutics Inc | 103,602 | $1.917M | 0.2% | $25.45 | -27.7% | COMM | 427746102 |
| — | Kala Pharmaceuticals Inc | 478,206 | $1.819M | 0.2% | $5.38 | — | COMM | 483119103 |
| SNDX | Syndax Pharmaceuticals Inc | 243,150 | $1.817M | 0.2% | $6.52 | +39.6% | COMM | 87164F105 |
| ALGN | Align Technology Inc | 10,000 | $1.81M | 0.2% | $207.89 | 0.0% | COMM | 016255101 |
| — | Portola Pharmaceuticals Inc | 59,191 | $1.588M | 0.1% | $26.83 | — | COMM | 737010108 |
| — | Applied Therapeutics Inc | 142,004 | $1.56M | 0.1% | $8.24 | — | COMM | 03828A101 |
| — | Syndax Pharmaceuticals Inc | 200,000 | $1.494M | 0.1% | — | — | Put | 87164F955 |
| BCRX | BioCryst Pharmaceuticals Inc | 516,734 | $1.481M | 0.1% | $5.51 | -43.5% | COMM | 09058V103 |
| SVRA | Savara Inc | 527,318 | $1.397M | 0.1% | $2.50 | 0.0% | COMM | 805111101 |
| — | Synlogic Inc. | 574,972 | $1.317M | 0.1% | $9.38 | — | COMM | 87166L100 |
| APLS | Apellis Pharmaceuticals, Inc | 49,580 | $1.194M | 0.1% | $19.65 | +40.0% | COMM | 03753U106 |
| — | Heron Therapeutics Inc | 53,800 | $995K | 0.1% | — | — | Call | 427746902 |
| — | Sunesis Pharmaceuticals Inc | 1,133,947 | $816K | 0.1% | $0.72 | — | COMM | 867328700 |
| — | Syndax Pharmaceuticals Inc | 100,000 | $746K | 0.1% | — | — | Call | 87164F905 |
| PDSB | PDS Biotechnology Corporation | 142,635 | $482K | 0.0% | $8.36 | -30.4% | COMM | 70465T107 |